chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10:30 AM pt. broke out with red blotches on face. Blotches appeared within 5 minutes of injection, oral BENADRYL 3 ml given at 1045. Rash almost resolved at discharge.
I tested (+) on my pregnancy test on 07Jan2021; Mild chills; This is a spontaneous report from a contactable nurse (Patient).  A 30-years-old pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVI-19 VACCINE, Solution for injection, Batch/Lot Number: EJ1686), via intramuscular route of administration, administered in Deltoid Right on 06Jan2021 15:20 (Age at vaccination: 30-years-old) as single dose for covid-19 immunization. Medical history included colitis ulcerative from 01Jan2015 to an unknown date Currently taking Remicade IV infusions every 8 weeks. Concomitant medication included infliximab (REMICADE) taken for Ulcerative colitis from 04Feb2020 and ongoing. It was reported that patient received covid-19 vaccine both doses on 26Dec2020 and 06Jan2021 respectively. she tested positive on her pregnancy test on 07Jan2021. Currently, under a care of her high risk (obstetrician) OB. She is 9 weeks pregnant. she would like to make us aware of it, Since she know, these not a lot of data about pregnancies and vaccine. she is willing to be in a study or research for observation. It was also reported that patient experienced Very mild chills 11 hours after second dose. Patient did not receive any treatment for the event. Adverse event not resulted in Emergency room or Physician office visit. Patient did not receive any treatment for the event. The mother reported she became pregnant while taking bnt162b2. The mother was 9 Weeks pregnant at the onset of the event. The patient underwent lab tests and procedures which included pregnancy: positive on 07Jan2021. The outcome for the event Very mild chills was reported as resolved on 2021.   Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Information has been received from a pharmacist concerning a 66 year old male patient. On 05-FEB-2015 the patient was vaccinated with a dose of ZOSTAVAX, (lot#, expiration date, route and dose not provided) in his right arm. On 06-FEB-2015 the patient developed a rash on the right side of his stomach. The patient called to report this rash to the pharmacist on 17-FEB-2015. The outcome of this event was reported as recovering. The reporter did not assess the causality. Additional information has been requested.
complaining of /nausea and dry heaves, hot/cold flashes, tingling to fingers/toes, peri-oral with both doses.
This spontaneous report as received from a nurse refers to roughly 20 unspecified patients of unknown age. On an unknown date, roughly 20 unspecified patients were vaccinated with VARIVAX (injection, strength, dose, frequency, route of administration and indication were not provided) that reached 18.5 F for 10 hours and 44 minutes. This range was outside of storage conditions in product insert; however, in house stability data can support those conditions mentioned above that the VARIVAX was exposed to. No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was reported. The outcome of events was unknown. No further adverse event information was available. Follow up information has been received from nurse providing information VARIVAX temperature excursion such as affected lot numbers, expiration dates and patient ID. was vaccinated with VARIVAX injection, (strength, dose, frequency, route of administration and indication were not provided) (lot# J008652, exp. date: 10-JUL-2015) that reached 18.5 F for 10 hours and 44 minutes. This is one of several reports received from the same source. Additional information has been requested.
Had a flu shot 1 time Got the flu; Initial information received on 06-Nov-2020 regarding an unsolicited valid non-serious social media case from consumer (Patient) via social media.  This case involved a patient with unknown demographic who had a flu shot 1 time got the flu (Influenza), while he received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had a flu shot 1 time got the flu (Influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown for the event.  There will be no information on the batch number for this case.
01/06/2022: cough, ST, HA, night sweats and NC.
Awoke with overall body aches, especially in hips. Went to restroom. After using restroom & while still in bathroom - experienced simultaneous onslaught of several effects, such as hot, chills, sweaty, nauseous - perhaps more but too overwhelmed to process or remember. Next realized was lying on floor & got up to leave the room. Next heard husband speaking to me. Was lying on the floor again. I now know that I lost consciousness twice and fell both times. (2d fall was worse, chin first, resulting in much bruising, some significant, and sore muscles.) I could not stand on my own. Husband helped me & supported me walking back to bed where I lay down again. My breathing was heavy & my entire body felt as if it were vibrating. Other sensations might have been happening, but I can't remember. The sensations slowly subsided. I have had four prior Covid vaccines: (1) Pfizer 04/10/2021; (2) Pfizer 05/01/2021; (3) Pfizer 12/02/2021; and (4) Pfizer TRIS 07/18/2022. With each shot, I experienced mild aches, pains, & fatigue starting about 12 hours after the shot and continuing for about 16-24 hours after that. I have never had COVID that I am aware of.
Sore arm at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 20:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC); both for unknown indications from unknown dates and unknown if ongoing. On 04Mar2021 at 03:00, the patient experienced a sore arm at the site of injection. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm at site of injection was resolved on 04Mar2021.  No follow-up attempts are needed. No further information is expected.
blister; itching; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blister) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (blister) and PRURITUS (itching). At the time of the report, BLISTER (blister) and PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported.
Lt arm redness/warmth/swelling form deltoid to elbow, with elbow effusion. Was admitted and treated for cellulitis. - 4/13/06 Review of 11-page d/c summary confirms diagnosis of cellulitis and a secondary diagnosis of viral syndrome. Initially had a fever of 101 and vomiting.  She was treated with IV antibiotics and prescribed Keflex PO for 7 days after. Date of immunization should be changed to 02/17/2006. Additional vaccines given that day include PPV (Merck, 0746P, right arm) and flu (AP, U1868AA, right arm).
Information has been received from a physician concerning a 4 year old female with no medical history who, in 2004, was vaccinated with a first dose of MMR II and on 23-JUL-2008 was vaccinated with a second dose of MMR II (lot number: 659705/0356X). Suspect vaccination included a dose of VARIVAX (Merck). Other concomitant therapy included a dose of IPOL and a dose of Tdap. On 31-JUL-2008, the patient experienced front right facial swelling that was mumps-like. The patient was treated with antibiotics. The patient was seen by a dentist and the swelling was not related to her teeth. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested.
seasonal allergies; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SEASONAL ALLERGY (non-serious), outcome "unknown", described as "seasonal allergies"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat".  Additional information: The patient was scheduled to take his 2nd dose of Covid-19 Vaccine the next day.  No follow-up attempts are possible. Information about lot or batch number cannot be obtained. No further information is expected.
Diagnosed with covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Diagnosed with covid) in a 94-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 02-Oct-2022, the patient experienced COVID-19 (Diagnosed with covid). At the time of the report, COVID-19 (Diagnosed with covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Oct-2022, SARS-CoV-2 test: (Positive) The patient was not hospitalized..         No concomitant medication was reported.   The patient received all of the vaccines from Moderna but had no lot numbers.  Patient's symptoms started before diagnosis which included felt like a Cold and mucous. Patient had not experienced a similar event in the past.  The patient was treated with unspecified medication but could not recall.
Pt. states that after receiving the 1st dose of Phizer 07/26/2021, started experiencing symptoms 07/28/2021 of muscle aches, bone aches, joint pain, right side of the head pain, right knee pain, and weakness throughout the body. Primary visit 08/23/2021 recommended self reporting to VAERS. Blood work orders (antibodies).
Patient developed fever 101.4 degrees F, chills, body aches. Abdominal pain and diarrhea started 12-30-14. Fever subsided 12-31-14; increased sweating starting 12-28-14.
Patient felt nauseous. Patient instructed to lie down for 30 mins. Patient felt better and sent home with mother.
Patient said he went to see doctor a little while after shot about left shoulder pain,  doctor said shot was giver a litter higher in the shoulder
Possible heart attack on 2/5/21. Complaint: " On Feb 5th l believe l experienced a mild hear attack"  (Comment: He said he felt "clammy, sweaty, excruciating pain on my left side - including his left arm, and left leg, dizzy, exhausted." This happened after work, and after taking a shower. He said that was the first time he's experienced it, and that it has not happened since then. He said he has constant headaches, "It just went away yesterday."
Pt recvd rubella vax on 11APR91 & on 22APR91 pt devel fever, malaise, arthralgia, & rash; sx lasted approx 3 days & resolved;
Itchy rash on the arm I received the vaccine; warm to the touch but not painful.
Per Client received Pfizer COVID 19 vaccine second dose on 3/28/2021, at 1:00pm in left arm. Client C/O symptoms starting on 3/28/2021 around 9:00pm, fever and chills. ON 3/30/2021 started having difficulty with breathing, chest pain, racing pulse an increased blood pressure through 3/31/2021, so the Client went into the ER on 3/31/2021. In ER Client had a CT of chest performed and is currently wearing a internal heart monitor for other medical concerns present prior to vaccine. Per Client some of symptoms have subsided and Client will plan to follow up with PCP. PHN suggested that Client continue to monitor symptoms, follow up with PCP and go back to ER if needed and call 911 for medical emergency.
This spontaneous report was received from a pharmacist and refers to a patient of unspecified age and gender. There was no information regarding the patient's medical history, concurrent conditions, concomitant therapies, and drug reactions or allergies. On 10-OCT-2016, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously, (anatomical location, dose, lot number, and expiration date were not provided), for prophylaxis. Subsequently, on 08-FEB-2017, the patient was vaccinated with other dose of ZOSTAVAX, subcutaneously, (anatomical location, dose, lot number, and expiration date were not provided), dose and frequency reported as "single dose bothe times", for prophylaxis. No product quality complaint was involved. Additional information is not expected as there was no consent to contact the physician.
Hi, our primary told us to make a report. My husband was down (but totally functioning) due to a reduction in force (thank you COVID). However, after his second dosage...within 1-2 weeks he declined to the point he became comatose. He could NOT talk/function/eat sleep. He was hospitalized for almost 1 month. He is still not functioning and now on heavy duty meds that have not made an impact. Our doc believes the vaccine triggered something in his brain. It has been so scary to see this. He had to take a leave from his new job. I honestly cannot believe all of this happened as I have heart nothing but good things from the vaccine. We are NOT telling a lot of people because we do not want to freak anyone out. Most folks do well...but my husband is very ill. We need more help. He went from a strong CPA who worked out every day, took great care of himself...to a sick person who lost over 30lbs. He is absolutely petrified to leave the house. We are living in a nightmare and it's taken a toll on him, myself, and our daughter. If there is anyone else who can help us...please contact us. We have been going to docs...and we still cannot get to the bottom of this. I am so sorry we had to even report this. We pray no one else goes through this.
Sore arm at injection site with both shots. With the second shot only: Next day @ Approximately 7:00 am started feeling dizzy. Approximately noon stated feeling chills and general body aches. 6:00 pm took ibuprofen and slept until 6:00 am next day . All symptoms then gone
stated she felt dizzy within the 15 minute wait time after being immunized. I broke an ammonia inhalant and use a cool compress on her face because she had started to sweat.  Her boyfriend who was with her stated had not eaten anything before she came in to be vaccinated.  Patien t stated she felt better after inhaling the ammonia and using the cool ompress. Patient stated she felt a little burning in her arm, but that went away.
Was given Pfizer BioNtech vaccine 67 minutes after expiration time.  Had robust immune response with swollen axilla lymph nodes on side of immunization.
I received my first injection on Friday, January 22.   On January 31, I woke with a red rash (welts) at the injection site, very red and sore and itchy.  On February 1, it was less red and sore but still itchy.  Today, February 4, I still have a few welts and still itchy.
Swelling, redness pain to left deltoid. 11 year old male patient here due to allergic reaction c/o swelling, redness, pain at the injection site, L deltoid. Afebrile. No v/d.
Redness, stiffness, warm and painful to the touch. No fevers or aches other than to the local area.
ADMINISTERED VACCINE ON 28-JUL-2021 FROM VIAL PUNCTURED ON 27-JUL-2021; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 21-SEP-2021) dose was not reported, administered on 28-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced administered vaccine on 28-Jul-2021 from vial punctured on 27-Jul-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from administered vaccine on 28-Jul-2021 from vial punctured on 27-Jul-2021. This report was non-serious.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment details were reported.  Reporter stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Febrile seizure - went to ER, had 104 fever.  Resolved on own
Arm muscle ache- almost immediately- Ongoing  Whole body aches- 5:30 AM 03/11/2021- Ongoing  Fever- 10:30 AM 03/11/2021- Ongoing
Patient experienced dizziness and heart palpitations. Went home to rest. Had a fever in the evening.
Extreme discomfort in armpit of right arm; Swollen and hard to lift arm; Swollen and hard to lift arm; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 23Apr2021 14:15 (Lot number: EW0153) at the age of 23 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Spice allergy" (unspecified if ongoing), notes: Known allergies: cinnamon; "Dermatitis contact" (unspecified if ongoing), notes: Known allergies: adhesive; "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin; "Attention deficit hyperactivity disorder" (unspecified if ongoing), notes: ADHD; "Mast cell activation syndrome" (unspecified if ongoing), notes: MCAS; "Postural orthostatic tachycardia syndrome" (unspecified if ongoing), notes: POTS; "Ehlers-Danlos syndrome" (unspecified if ongoing). Concomitant medication(s) included: STRATTERA; LORATADINE; VITAMIN D [VITAMIN D NOS]; ZINC. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: ER8730, Administration time:14:15), administration date: 02Apr2021, when the patient was 23 years old, for COVID-19 immunisation. The following information was reported: AXILLARY PAIN (non-serious) with onset 23Apr2021 18:00, outcome "not recovered", described as "Extreme discomfort in armpit of right arm"; PERIPHERAL SWELLING (non-serious), MOBILITY DECREASED (non-serious) all with onset 23Apr2021 18:00, outcome "not recovered" and all described as "Swollen and hard to lift arm". Therapeutic measures were not taken as a result of axillary pain, peripheral swelling, mobility decreased.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient reported, the first shot did not hurt her armpit that way. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were not taken as a result of the events.   No follow-up attempts are possible. No further information is expected.
Patient noticed rash on arm near injection site 1-2 days after vaccine. Said she itched area. Then rash went down arm. Advised patient to see MD. Patient went to back in clinic patient first. They gave her antibiotic. No steroid. Said to follow up with them. Patient previously used ice at first. Partial itching area may have caused infection.
He reported that he woke up at 0400 on 04 July 19 with pressure in the center of his chest that increased with deep breaths. Rated pain # 8-9 on scale of 1-10. Pain increased when he took a deep breath while lying on his back, and constant pain when on stomach. He reported SOB, and radiation to his neck. He denied palpitations, diaphoresis and N/V. Never had pain like this before and was diagnosed as having myopericarditis, pos enzymes and EKG changes. He currently reported that he is feeling well, taking meds as directed and will have rare episodes of pain lasting only a couple of minutes
PATIENT WENT TO ASK PHARMACIST A QUESTION ABOUT EFFICACY OF VACCINE USING HIS PHONE.  AS PHARMACIST WAS LOOKING AT THE PATIEN'TS PHONE, HIS WIFE JUST GAVE PATIENT A SHOT OF THE VACCINE WITHOUT CONSULTING THE PHARMACIST.
Violent vomiting, weakness, fever (measured at 7:30 PM - 100.7), pain in abdomen, weak, not able to sleep. called doctor, gave Tylenol.   Symptoms continue into night (*5:00AM - 100.3 fever), still feels like throwing up, still has pain in abdomen.  Weak.  Doctor stated they felt no relation to shot, but son has not been sick in 4 years, healthy no sickness prior to shot.
soreness in arm where they shot him; chest pain; This is a spontaneous report from a contactable reporter (patient) via the Pfizer sponsored program. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm on 28Feb2021, (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included congestive heart failure and chest pain.  The patient's concomitant medications were not reported.  On 28Feb2021, the patient experienced soreness in arm where they shot him and chest pain.  After encouraging caller to speak with his HCP about chest pain, patient stated chest pain is not new for him, he has congestive heart failure and has chest pain before the vaccine.  The patient is asking if it is safe to take Ibuprofen for treatment of symptoms. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.  No further information is expected.